Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 42.1% in November

Aethlon Medical, Inc. (NASDAQ:AEMD) was the target of a large drop in short interest during the month of November. As of November 30th, there was short interest totalling 203,400 shares, a drop of 42.1% from the November 15th total of 351,100 shares. Based on an average daily volume of 615,200 shares, the short-interest ratio is presently 0.3 days.

Analyst Ratings Changes

Several brokerages recently issued reports on AEMD. HC Wainwright restated a “buy” rating and issued a $7.00 target price on shares of Aethlon Medical in a report on Friday, November 15th. StockNews.com initiated coverage on Aethlon Medical in a research report on Tuesday. They set a “sell” rating on the stock.

Aethlon Medical Price Performance

AEMD opened at $0.37 on Friday. The firm has a market cap of $5.11 million, a P/E ratio of -0.13 and a beta of 1.79. Aethlon Medical has a 1-year low of $0.24 and a 1-year high of $2.35. The company has a 50 day simple moving average of $0.39 and a two-hundred day simple moving average of $0.42.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.